Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance

World Journal of Gastroenterology

Volumn 9, Issue 11, 2003, Pages 2450-2454

  Zhou, Qi ^a   He, Qiang ^a   Liang, Li Jian ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN E; PROTEIN P27;

ADULT; AGED; ARTICLE; ASSAY; CANCER CLASSIFICATION; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR THROMBUS; TUMOR VOLUME;

EID: 0344899173     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i11.2450     Document Type: Article

References (32)

1. Sheer CJ. Cancer cell cycles. Science 1996; 274: 1672-1678
2. Draetta GF, Mammalian G. Cyclins. Curr Opin Cell Biol 1994; 6: 842-846
3. Hartwell LA, Weinnert TA. Checkpoints: Control that ensure the order of cell cycle events. Science 1989; 246: 629-634
4. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 Cyclin dependent kinase protein kinase activity is related to p21. Cell 1994; 78: 67-71
5. Wimmel A, Lucibello FC, Sewing A, Adolph S, Muller R, Wimmel A. Inducible acceleration of G1 Progression through tetra cycline-regulated expression of human cyclinc E. Oncogene 1994; 9: 995-997
6. Pagano M, Pepperkoko R, Verde F, Ansorge W, Draetta G, Pagano M. Cyclin A is required at two points in the human cell cycle. EMBO J 1992; 11: 961-967
7. Hengst T, Reed SI. Translational control of p27kip1 accumulation during the cell cycle. Science 1996; 271: 1861-1864
8. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A. p27kip1, a Cyclin dependent kinase inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 1994; 8: 9-17
9. Harvat BL, Seth P, Jetten AM. The role of p27kip1 in gamma interferon mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cell. Oncogene 1997; 372: 570-573
10. Kato JY, Matsuoka M, Polyak K, Massague J, Sherr CJ. Cyclin AMP induce G1 phase arrest mediated by an inhibitor (p27kip1) of Cyclin dependent kinase 4 activation. Cell 1994; 79: 487-495
11. Ohtani M, Isozaki H, Fujii K, Nomura E, Niki M, Mabuchi H, Nishiguchi K, Toyoda M, Ishibashi T, Tanigawa N. Impact of the expression of Cyclin dependent kinase inhibitor p27kip1 and apoptosis in tumor cells on the overall survival of the patients with non-early stage of gastric carcinomas. Cancer 1999; 85: 1711-1718
12. Esposito V, Baldi A, De Luca A, Groger AM, Loda M, Giordano GG, Caputi M, Baldi F, Pagano M, Giordano A. Prognostic role of Cyclin dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 1997; 57: 3381-3385
13. Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH, Slingerland JM. Loss of Cyclin dependent kinase inhibitor p27kip1 is a novel prognostic factor in located human prostate adenocarcinoma. Cancer Res 1998; 58: 542-548
14. Tan P, Cady B, Wanner M, Worland P, Cukor B, Magi-Galluzzi C, Lavin P, Draetta G, Pagano M, Loda M. The cell cycle inhibitor p27 is an independent prognostic marker in small (Ta, Tb) invasive breast carcinomas. Cancer Res 1997; 57: 1259-1268
15. Takeuchi S, Koeffler HP, Hinton DR, Miyoshi I, Melmed S, Shimon I. Mutation and expression analysis of the Cyclin dependent kinase inhibitor gene p27kip1 in pituitary tumors. J Endocrinol 1998; 157: 337-342
16. Yao M, Zhou XD, Liu YK, Tang ZY. E-cadherin expression in invasive hepatocellular carcinoma. Zhonghua Xiaohua Zazhi 1998; 18: 31-33
17. Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Taniguchi N, Monden M. Expression and prognostic roles of the G1-Smodulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Hepatology 1999; 30: 90-99
18. Volm M, Koomagi R, Mattern J, Stammler G. Cyclin A is associated with an unfavourable outcome in patient with non-small-cell lung carcinomas. Br J Cancer 1997; 75: 1774-1778
19. Peng SY, Chou SP, Hsu HC. Association of down-regulation of Cyclin D and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma. J Hepatol 1998; 29: 281-289
20. Sgambato A, Cittadini A, Faraglia B, Weinstein IB. Multiple functions of p27kip1 and its alterations in tumor cell: A review. J Cell Physio 2000; 183: 18-27
21. Asessandrini A, Chiaur OS, Pagano M. Regulation of the Cyclin dependent kinase inhibitor p27kip1 by degradation and phosphorylation. Leukemia 1997; 11: 342-345
22. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M. Role of the ubiquitin - Proteasome pathway in regulating abundance of the Cyclin dependent kinase inhibitor p27. Science 1995; 269: 682-691
23. Ferrando AA, Balbin M, Pendas AM, Vizoso F, Velasco G, Lopez-Otin C. Mutational analysis of the human Cyclin dependent kinase inhibitor p27kip1 in primary breast carcinomas. Hum Genet 1996; 97: 91-94
24. Morosetti R, Kawamata N, Gombart AF. Alternation of the p27kip1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia lymphoma. Blood 1995; 86: 1924-1930
25. Levenberg S, Yarden A, Kam Z, Geiger B. p27 is involved in N-cadherin mediated contact inhibition of cell growth and S-phase entry. Oncogene 1999; 18: 869-876
26. Donnellan R, Chetty R. Cyclin E in human cancers. FASEB J 1999; 13: 773-780
27. Huntunem RL, Blomquist CP, Bohling TO. Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness. Cancer Res 1999; 59: 2885-2892
28. Ohashi R, Gao C, Miyazaki M, Hamazaki K, Tsuji T, Inoue Y, Uemura T, Hirai R, Shimizu N, Namba M. Enhanced expression of cyclin E and cyclin A in human hepatocellular carcinomas. Anticancer Res 2001; 21: 657-662
29. Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ. The murine gene p27 is haplo-inufficent for tumor suppression. Nature 1998; 396: 177-180
30. Zerfass-Thome K, Schulze A, Zwerschke W, Vogt B, Helin K, Bartek J, Henglein B, Jansen-Durr P. p27kip1 blocks Cyclin-E dependent transactivation of Cycline-A gene expression. Mol Cell Biol 1997; 17: 407-415
31. Marches R, Schenermann RH, Uhr TW. Cancer dormancy: Role of Cyclin-dependent kinase inhibitors in induction of cell cycle arrest mediated via membrane IgM. Cancer Res 1998; 58: 691-697
32. Pascale RM, Simile MM, De Miglio MR, Muroni MR, Calvisi DF, Asara G, Casabona D, Frau M, Seddaiu MA, Feo F. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis. Hepatology 2002; 35: 1341-1350